Assay of vitamin B12

• US 4,426,455 A
• Filed: 09/09/1981
• Issued: 01/17/1984
• Est. Priority Date: 09/22/1980
• Status: Expired due to Fees

• Current Assignee: Amersham International Limited
• Original Assignee: Amersham International Limited
• Inventors: Carrick, David T., Tovey, Keith C.
• Primary Examiner(s): Nucker, Christine M.
• Application Number:
  US06/300,979
• Time in Patent Office: 860 Days
• Field of Search: 424/1, 436/504, 436/505
• US Class Current: 436/505
• CPC Class Codes: G01N 33/82 involving vitamins or their receptors
• CPC Class Codes: Y10S 436/825 Pretreatment for removal of interfering factors from sample

Abstract

A method of assaying for vitamin B12 achieves denaturation of serum binding proteins which normally bind the vitamin B12 by treatment with alkali at ambient temperature. The assay is characterized by the use, in the alkali denaturation step, of a dithiopolyol and cyanide, and by the use, during the intrinsic factor assay step, of a vitamin B12 analogue such as cobinamide to bind with any remaining serum proteins. The invention also includes a kit, in which the dithiopolyol is provided in admixture with the alkali.

Claims

1. A method of assaying for vitamin B₁₂ in serum comprising the steps

(a) mixing a sample of the serum to be assayed with alkali, cyanide, and a dithiopolyol having from 4 to 6 carbon atoms.

(b) incubating the mixture at a pH of at least 12 and a temperature not exceeding 50°

C. for a time sufficient to separate the vitamin B₁₂ from serum binding proteins and to substantially denature the proteins,

(c) providing in the mixture, either before, during or after performing step (b), a standard amount of radioactively labelled vitamin B₁₂, and a vitamin B₁₂ analogue which binds strongly to serum binding proteins of the sample but not to intrinsic factor,

(d) reducing the pH of the incubated mixture from step (b), adding thereto a standard amount, insufficient to bind all the vitamin B₁₂ in the sample and the radioactively labelled vitamin B₁₂, of intrinsic factor, and

(e) incubating the mixture to cause a fraction of the vitamin B₁₂ in the sample and a fraction of the radioactively labelled vitamin B₁₂ to become bound to the intrinsic factor, separating the bound fraction from the fraction not so bound, measuring the level of radioactivity of at least one fraction, and using the measurement to determine the concentration of vitamin B₁₂ in the sample.

2. A method as claimed in claim 1, wherein in step (a) the alkali and the dithiopolyol are added as a pre-formed mixture to the serum sample.

3. A method as claimed in claim 1, wherein the dithiopolyol is dithiothreitol or dithioerythritol.

4. A method as claimed in claim 1, wherein the vitamin B12 analogue is cobinamide.

5. A method as claimed in claim 1, wherein cyanide is used in step (a) in an amount equivalent to 20 to 200 μ

g of potassium cyanide/ml of serum.

6. A method as claimed in claim 1, wherein the dithiopolyol is used in step (a) in an amount of from 4 to 10 mg/ml of serum.

7. A method as claimed in claim 1, wherein the vitamin B12 analogue is used in an amount of from 10 to 1000 times that required to occupy all the binding sites of the serum binding proteins which have not been denatured by the step (b) incubation.

8. A kit for performing an assay of vitamin B12 in serum comprising supplies of alkali, a dithiopolyol having 4 to 6 carbon atoms, cyanide, radioactively labelled vitamin B12, intrinsic factor, and a vitamin B12 analogue which binds strongly to serum binding proteins in serum but not to intrinsic factor, wherein the supplies of alkali and dithiopolyol are provided in admixture.

9. A kit as claimed in claim 8, wherein the supplies of radioactively labelled vitamin B12 and cyanide are provided in admixture.

10. A kit as claimed in claim 8, wherein the vitamin B12 analogue is cobinamide.